119. Kohno M, Ikeda M, Jonchi M, Horio T, Yasunari K, Kurihara N, Takeda T.Interaction of PDGF and natriuretic peptides on mesangial cell proliferation andendothelin secretion. Am J Physiol 1993;265:E673-9.120. Ong ACM, Jowett TP, Moorhead JF, Owen JS. Human highdensity lipoproteinsstimulate endothelin-1 release by cultured human renal proximal tubular cells. KidneyInt 1994;46:1315-21.121. Malek AM, Greene AL, Izumo S. Regulation of endothelin-1 gene by fluid shearstress is transcriptionally mediated and independent of protein kinase C and cAMP.Proc Natl Acad Sci USA 1993;90:5999-6003.122. Bird JE, Waldron TL. Endogenous synthesis of endothelin-1 may mediate a delayedpressor response after injection of endothelin-1 in rats. J Cardiovasc Pharmacol1995;25:307-13.123. Morel DR, Lacroix JS, Hemsen A, Steinig DA, Pittet J-F, Lundberg JM. Increasedplasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur JPharmacol 1989;167:427-8.124. Zimmermann RS, Maymind M, Barbee RW. Endothelin blockade lowers totalperipheral resistance in hemorrhagic shock recovery. Hypertension 1994;23:205-10.125. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Cell signalling. In:Molecular biology of the cell. New York and London: Garland Publishing Inc.,1994:721-87.126. Masaki T, Vane JR, Vanhoutte PM. V. International union of pharmacologynomenclature of endothelin receptors. Pharmacol Rev 1994;46:137-42.127. Karne S, Jayawickreme CK, Lerner MR. Cloning and characterization of anendothelin-3 specific receptor (ETc receptor) from Xenopus laevis dermalmelanophores. J Biol Chem 1993;268:19126-33.128. Douglas SA, Meek TD, Ohlstein EH. Novel receptor antagonists welcome a new era inendothelin biology. Trends Biochem Sci 1994;15:313-6.129. Masaki T. Endothelins: Homeostatic and compensatory actions in the circulatory andendocrine systems. End Rev 1993;14:256-68.130. Miller RC, Pelton JT, Huggins JP. Endothelin - from receptors to medicine. TiPS1993;14:54-60.131. Adachi M, Furuichi Y, Myamoto C. Identification of a ligand-binding site of thehuman endothelin-A receptor and specific regions required for ligand selectivity. Eur J115
Biochem 1994;220:37-43.132. Becker A, Haendler B, Hechler U, Schleuning W-D. Mutational analysis of humanendothelin receptors ET A and ET B . Eur J Biochem 1994;221:951-8.133. Krystek, Jr SR, Patel PS, Rose PM, Fisher SM, Kienzle BK, Lach DA, et al. Mutationof peptide binding site in transmembrane region of a G protein-coupled receptoraccounts for endothelin receptor subtype selectivity. J Biol Chem 1994;269:12383-6.134. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of acDNA encoding an endothelin receptor. Nature (London) 1990;348:730-2.135. Sakurai T, Yanagisava M, Takuva Y, Miyazaki H, Kimura S, Goto K, Masaki T.Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelinreceptor. Nature (London) 1990;348:732-5.136. Simonson MS, Dunn MJ. Cellular signaling by peptides of the endothelin gene family.FASEB J 1990;4:2989-3000.137. Jouneaux C, Mallat A, Serradeil-Le Gal C, Goldsmith P, Hanoune J, Lotersztajn S.Coupling of endothelin B receptors to the calcium pump and phospolipase C via Gsand Gq in rat liver. J Biol Chem 1994;269:1845-51.138. Jouneaux C, Goldsmith P, Hanoune J, Lotersztajn S. Endothelin inhibits the calciumpump and stimulates phosphoinositide phospholipase C in liver plasma membranes viatwo different G proteins, Gs and Gq. J Cardiovasc Pharmacol 1993; 22(Suppl 8):S158-60.139. Sokolovsky M. Endothelin receptors in rat cerebellum: activation of phospho-inositidehydrolysis is transduced by multiple G-proteins. Cell Signall 1992;5:473-83.140. Galron R, Bdolah A, Kloog Y, Sokolvsky M. Endothelin/ sarafotoxin receptor inducedphosphoinositide turnover: Effects of pertussis and cholera toxins and of phorbol ester.Biochem Biophys Res Commun 1990;171:949-54.141. Baldi E, Musial A, Kester M. Endothelin stimulates phosphatidylcholine hydrolysisthrough both PLC and PLD pathways in mesangial cells. Am J Physiol1994;266:F957-65.142. Kester M, Simonson MS, MxDermott RG, Baldi E, Dunn MJ. Endothelin stimulatesphosphatidic acid formation in cultured rat mesangial cells: Role of a protein kinase C-regulated phospholipase D. J Cell Physiol 1992;150:578-85.143. Schramek H, Wang Y, Konieczkowski M, Rose PM, Sedor JR, Dunn MJ. Endothelin-1 stimulates cytosolic phospholipase A2 in Chinese hamster ovary cells stably116
- Page 2 and 3:
SVEUČILIŠTE U ZAGREBUMEDICINSKI F
- Page 4 and 5:
POPIS KRATICAACEangiotenzin konvert
- Page 6 and 7:
3. ISPITANICI i METODE.............
- Page 8 and 9:
1.1. RENIN ANGIOTENZIN SUSTAV (RAS)
- Page 10 and 11:
Slika 2. "Novi" koncept klasičnog
- Page 12 and 13:
1.1.1. AngiotenzinogenSupstrat reni
- Page 14 and 15:
i renina nađene su i u neferktomir
- Page 16 and 17:
Snižena plazmatska aktivnost renin
- Page 18 and 19:
Slika 3. Shematski prikaz krvožiln
- Page 20 and 21:
Izvanplućna konverzija angiotenzin
- Page 22 and 23:
Radovi Osborna i Studera (65,66) i
- Page 24 and 25:
Naša su istraživanja pokazala da
- Page 26 and 27:
1.1.7. Angiotenzin (1-7)Angiotenzin
- Page 28 and 29:
(114,115). Sve je više dokaza za p
- Page 30 and 31:
Slika 6. Mehanizam djelovanja endot
- Page 32 and 33:
Strukturno vrlo sličan ljudskim en
- Page 34 and 35:
afinitetom receptora (135). Cistein
- Page 36 and 37:
Uloga endotelina u patofiziologiji
- Page 38 and 39:
1.2.3.1. Učinci na kardiovaskularn
- Page 40 and 41:
1.2.4.2. Učinci ET-1 na regulaciju
- Page 42 and 43:
učinkom prostaglandin E2 relaksira
- Page 44 and 45:
subendotelijalnom prostoru. Naime,
- Page 46 and 47:
U in vivo uvjetima, neaktivne KC zd
- Page 48 and 49:
Molekularnim pristupom u istraživa
- Page 50 and 51:
s maksimumom nakon 48 sati (nakon g
- Page 52 and 53:
ožiljka. U oba tipa odgovora prisu
- Page 54 and 55:
dva inhibitora metaloproteinaza se
- Page 56 and 57:
Kao što je već prethodno istaknut
- Page 58 and 59:
Sintezu ET-1 među ostalim podstič
- Page 60 and 61:
3.1. IspitaniciU istraživanje je u
- Page 62 and 63:
3.2.2.Ultrazvučna pretraga i dople
- Page 64 and 65: Slika 10. Indeks otpora (RI) protok
- Page 66 and 67: 4. REZULTATI67
- Page 68 and 69: Tablica 7. Značajniji laboratorijs
- Page 70 and 71: Serumske aktivnosti ACE, serumske k
- Page 72 and 73: Indeks otpora (RI) u jetrenoj arter
- Page 74 and 75: Granične vrijednosti serumske akti
- Page 76 and 77: Slika 16. Prikaz granične vrijedno
- Page 78 and 79: Slika 18. Prikaz granične vrijedno
- Page 80 and 81: Slika 20. Prikaz serumske koncentra
- Page 82 and 83: Slika 22. Prikaz serumske aktivnost
- Page 84 and 85: 5. RASPRAVA85
- Page 86 and 87: dinamičke sastavnice koja je modif
- Page 88 and 89: Poznato je da u ovih bolesnika rast
- Page 90 and 91: ET-1 preko ET A receptora smješten
- Page 92 and 93: važan je modulator vaskularnog tla
- Page 94 and 95: Nije jasan razlog ovakvim disonantn
- Page 96 and 97: 1. Serumska aktivnost ACE i serumsk
- Page 98 and 99: Dosadašnja istraživanja su pokaza
- Page 100 and 101: korištenja ovih doplerskih paramet
- Page 102 and 103: Former research showed elevated val
- Page 104 and 105: 9. L I T E R A T U R A105
- Page 106 and 107: 13. Dell'Italia LJ, Meng QC, Balcel
- Page 108 and 109: of the angiotensin I-converting enz
- Page 110 and 111: diabetes type, state of metabolic c
- Page 112 and 113: medulla. Am J Physiol 2002;283:H181
- Page 116 and 117: expressing the human ETA or ETB rec
- Page 118 and 119: 170. Gandhi CR, Stephenson K, Olson
- Page 120 and 121: 1998;18:629-38.198. Sato E, Simpson
- Page 122 and 123: esponse of α2(I) collagen to trans
- Page 124 and 125: Primary rat and mouse hepatic stell
- Page 126 and 127: Plasma endothelin levels in cirrhot
- Page 128 and 129: 10. Ž I V O T O P I S129